Adult Primary and Preventive Practice (APPP) Study

Qure Healthcare, LLC213 enrolled

Overview

The study is a pre-post two round, randomized controlled study design of PCPs randomly assigned to a control or 1 of 2 intervention arms.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

SINGLE

Enrollment

213

Conditions

Preventive Care

Interventions

Educational materials on a new diagnostic serviceOTHER

Educational materials on a new diagnostic service

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 1\. Provide consent to participate in the study 2. Board-certified physician currently practicing in the following areas: 3. Internal medicine 4. Family medicine 5. Have practiced as a board-certified physician in internal or family medicine for greater than 2 but less than 30 years. 6. English-speaking 7. Community / non-academic based practice setting 8. ≥ 40 patients under care weekly 9. Access to the internet Exclusion Criteria: * 1\. Not board certified in their respective area of care 2. Academic-based practice 3. Have practiced as a board-certified physician for less than 2 or greater than 30 years 4. Follow \<40 patients weekly 5. Non-English speaking 6. Unable to access the internet

Locations (1)

QURE Healthcare

San Francisco, California, United States

Outcomes

Primary Outcomes

Quality of Care

Difference in difference of combined diagnostic and treatment CPV domain scores, including colonoscopy referral rates, in post-intervention versus baseline comparing intervention and control groups among the three patient types.

Time frame: 8 weeks

Secondary Outcomes

Intervention Impact on Care

Difference in difference between the control and intervention groups in the overall quality of care for CRC screening and for adult primary prevention care measured by the combined and individual item CPV scores for the three patient types.

Time frame: 8 weeks

Healthcare Utilization

Difference in health care utilization and/or costs in patients tested with SimpliPro Colon™ versus the control group.

Time frame: 8 weeks

Diagnostic Method Comparison

Difference in recommendation of CRC evaluation with colonoscopy and/or flexible sigmoidoscopy, double barium enema, or CT colonography, including risk-level and urgency pre- and post-intervention, between intervention and control groups

Time frame: 8 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.